Cargando…
SUN-337 Low Dose Ethinyl Estradiol in Women with Cystic Fibrosis Does Not Preserve Bone Mass
BACKGROUND: Cystic fibrosis-related bone disease (CFBD) affects 26% of adults with cystic fibrosis (CF). CFBD increases the risk for fractures, which in turn limits patients’ ability to effectively perform daily therapies necessary to maintain health. Factors contributing to CFBD include nutritional...
Autores principales: | Wu, Malinda, Hunt, William R, Tirouvanziam, Rabindra, Putman, Melissa Susan, Tangpricha, Vin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208184/ http://dx.doi.org/10.1210/jendso/bvaa046.810 |
Ejemplares similares
-
SUN-LB72 The Relationship Between Estrogen Exposure and Bone Health in Women With Cystic Fibrosis
por: Arora, Neha, et al.
Publicado: (2020) -
Oral ethinyl estradiol treatment in women with cystic fibrosis is associated with lower bone mineral density
por: Wu, Malinda, et al.
Publicado: (2020) -
Findings from a feasibility study of estradiol for hypogonadal women with cystic fibrosis-related bone disease
por: Wu, Malinda, et al.
Publicado: (2021) -
SUN-392 Bone Mineral Density and Body Mass Index in Men with Cystic Fibrosis
por: Jawahar, Abhinaya, et al.
Publicado: (2020) -
SAT-337 Ga-DOTATATE and Tumor Induced Osteomalacia: Finding the Culprit Lesion
por: Berman, Jessica, et al.
Publicado: (2020)